Gene Modulation by the Cyclooxygenase Inhibitor, Sulindac Sulfide, in Human Colorectal Carcinoma Cells
Open Access
- 1 July 2003
- journal article
- Published by Elsevier BV
- Vol. 278 (28), 25790-25801
- https://doi.org/10.1074/jbc.m301002200
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Selective cyclooxygenase‐2 inhibitors show a differential ability to inhibit proliferation and induce apoptosis of colon adenocarcinoma cellsFEBS Letters, 2002
- Cyclooxygenase-2—10 Years LaterJournal of Pharmacology and Experimental Therapeutics, 2002
- Chemoprevention of colorectal cancerThe American Journal of Gastroenterology, 2002
- Progression and NSAID-induced apoptosis in malignant melanomas are independent of cyclooxygenase IIMelanoma Research, 2001
- COX‐2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX‐2 inhibitor celecoxibThe FASEB Journal, 2001
- Cyclooxygenase‐independent actions of cyclooxygenase inhibitorsThe FASEB Journal, 2001
- Growth inhibition and induction of apoptosis in colorectal tumor cells by cyclooxygenase inhibitorsCarcinogenesis: Integrative Cancer Research, 2001
- Chemoprevention of Colorectal CancerNew England Journal of Medicine, 2000
- Cyclooxygenase-2 Inhibitors in Tumorigenesis (Part II)JNCI Journal of the National Cancer Institute, 1998
- Cyclooxygenase-2 Inhibitors in Tumorigenesis (Part I)JNCI Journal of the National Cancer Institute, 1998